Edison issues report on Percheron Therapeutics clinical strategy
TradingView reports Edison issued a report on Percheron Therapeutics, highlighting an investigator-sponsored exploratory study of HMBD-002 in acute myeloid leukaemia (AML).
London, United Kingdom--(. - September 4, 2026) - Edison issues report on Percheron Therapeutics ASX:PERPercheron's clinical strategy has taken an important turn with the announcement of an investigator-sponsored exploratory study of HMBD-002 in acute myeloid leukaemia (AML) and myelod…